rs1036199
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032782.5(HAVCR2):c.419G>T(p.Arg140Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.834 in 1,600,776 control chromosomes in the GnomAD database, including 558,802 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_032782.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAVCR2 | NM_032782.5 | c.419G>T | p.Arg140Leu | missense_variant | 3/7 | ENST00000307851.9 | NP_116171.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAVCR2 | ENST00000307851.9 | c.419G>T | p.Arg140Leu | missense_variant | 3/7 | 1 | NM_032782.5 | ENSP00000312002.4 |
Frequencies
GnomAD3 genomes AF: 0.834 AC: 126877AN: 152096Hom.: 53052 Cov.: 33
GnomAD3 exomes AF: 0.865 AC: 203321AN: 234978Hom.: 88469 AF XY: 0.868 AC XY: 109633AN XY: 126330
GnomAD4 exome AF: 0.834 AC: 1208317AN: 1448562Hom.: 505713 Cov.: 34 AF XY: 0.837 AC XY: 602396AN XY: 719370
GnomAD4 genome AF: 0.834 AC: 126972AN: 152214Hom.: 53089 Cov.: 33 AF XY: 0.840 AC XY: 62552AN XY: 74438
ClinVar
Submissions by phenotype
Subcutaneous panniculitis-like T-cell lymphoma Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied by a panel of primary immunodeficiencies. Number of patients: 94. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at